Dr Nicholas Appelbaum is the CEO and Co-Founder of Dosium. He is a medication safety expert with roots in frontline surgery – driven by the urgent need to tackle life-threatening drug errors. After moving to the UK to complete a PhD at Imperial College London, he worked with Lord Ara Darzi, examining how prescribing decisions are made under pressure. A Member of the Royal College of Surgeons, Fellow of the British Computer Society, and previous holder of research fellowships from the Resuscitation Council and NIHR, Nicholas has built his career pushing the boundaries of patient safety.
As Clinical Lead at the Helix Centre, Nicholas spearheaded the creation of Dosium in 2020, delivering a new decision support tool to allow clinicians in emergencies to prescribe more safely. His vision led to a collaboration with the Royal Pharmaceutical Society, to put the BNF at the heart of UK drug safety software.
Today, Nicholas continues to shape the future of healthcare as an Honorary Research Fellow at Imperial College London’s Institute of Global Health Innovation and Patient Safety Research Centre.